Hideko Ohama

61PUBLICATIONS
185CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Condensed matter imagingPeriodonticsHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Jul 20, 2026
Baseline DCP May Modify Response to Atezolizumab-Bevacizumab Versus Durvalumab-Tremelimumab in Unresectable HCC.

|Jul 16, 2026
Simplified BALAD (BALAD-S) Score as a Guide for First-Line Immune Checkpoint Inhibitor Selection for Unresectable Hepatocellular Carcinoma.

|Jun 23, 2026
Attenuation imaging and hepatorenal index composite score for the noninvasive assessment of hepatic steatosis in chronic liver disease: a prospective multicenter study.

|Jun 17, 2026
Cell-type-specific actions of carnosic acid against Porphyromonas gingivalis-induced proliferation in liver cancer cells.

|May 23, 2026
Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial.

|May 12, 2026
Evidence-Based Clinical Practice Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 2026.

Pageof 11

Frequent Collaborators

30 joint publications

Hidenori Toyoda

28 joint publications

Takashi Kumada

27 joint publications

Toshifumi Tada

26 joint publications

Kazuhito Kawata